U.S. Markets open in 1 hr 37 mins
  • S&P Futures

    4,405.50
    +56.50 (+1.30%)
     
  • Dow Futures

    34,510.00
    +325.00 (+0.95%)
     
  • Nasdaq Futures

    14,386.25
    +245.50 (+1.74%)
     
  • Russell 2000 Futures

    2,031.40
    +30.10 (+1.50%)
     
  • Crude Oil

    86.40
    +0.80 (+0.93%)
     
  • Gold

    1,846.40
    -6.10 (-0.33%)
     
  • Silver

    23.97
    +0.07 (+0.31%)
     
  • EUR/USD

    1.1287
    -0.0019 (-0.1693%)
     
  • 10-Yr Bond

    1.7830
    0.0000 (0.00%)
     
  • Vix

    28.65
    -0.20 (-0.69%)
     
  • GBP/USD

    1.3519
    +0.0013 (+0.0933%)
     
  • USD/JPY

    114.1550
    +0.2890 (+0.2538%)
     
  • BTC-USD

    37,849.70
    +1,227.18 (+3.35%)
     
  • CMC Crypto 200

    864.43
    +53.83 (+6.64%)
     
  • FTSE 100

    7,505.57
    +134.11 (+1.82%)
     
  • Nikkei 225

    27,011.33
    -120.01 (-0.44%)
     

Tandem Diabetes Care to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • TNDM

SAN DIEGO, November 18, 2021--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, is scheduled to participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference on December 2, 2021.

In advance of the virtual conference, a pre-recorded fireside chat with John Sheridan, President and Chief Executive Officer, and Leigh Vosseller, Executive Vice President and Chief Financial Officer, will be made available on Monday, November 22 at 10:00am Eastern Time (7:00am Pacific Time). Interested parties may access the fireside chat by visiting the Tandem Diabetes Care Investor Center website located at http://investor.tandemdiabetes.com in the "Events & Presentations" section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211118006015/en/

Contacts

Media Contact:
Steve Sabicer
714-907-6264
ssabicer@thesabicergroup.com

Investor Contact:
Susan Morrison
858-366-6900
IR@tandemdiabetes.com